See also: Opportunistic Illnesses and Related Conditions (General Information) and pages for particular opportunistic illnesses
Guidelines and General Information
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (CDC, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America)
- Guidelines for Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children
- Strategies for Managing Opportunistic Infections (Project Inform)
- HIV Opportunistic Infections (Avert) – see sections on prevention and treatment
- Drugs to Treat Opportunistic Infections (AIDS InfoNet) – this web page lists fact sheets for drugs used to prevent or treat opportunistic infections
Fact Sheets About Medications Used for Opportunistic Infections and Related Conditions from AIDS InfoNet:
- Azithromycin (Zithromax) and Spanish version
- Ciprofloxacin (Cipro) and Spanish version
- Clarithromycin (Biaxin) and Spanish version
- Dapsone (Avlosulfon) and Spanish version
- Fluconazole (Diflucan) and Spanish version
- Trimethoprim/Sulfamethoxazole and Spanish version
- Filgrastim (Neupogen) and Spanish version
- Pentamidine and Spanish version
- Atovaquone (Mepron) and Spanish version
Selected Recent Articles
- Package of prophylaxis against infections reduces the risk of death for people starting HIV treatment very late. (August 2016, AIDSmap)
- ART use averting huge numbers of opportunistic infections among children living with HIV in lower-income countries. (June 2016, AIDSmap)
- ‘Choosing Wisely’ in HIV Medicine – Should We Stop Giving MAC Prophylaxis? (March 2016, Journal Watch)
- ART has averted over 850,000 HIV-related opportunistic infections in low and middle income countries. (March 2016, AIDSmap)
- Senate committee holds hearing on Daraprim price increase, distribution agreements. (March 2016, Healio)
- Trial results boost evidence early ART plus IPT preserves health. (February 2015, Science Speaks Blog)
- Stopping cotrimoxazole during antiretroviral therapy raises risk of bacterial illness, malaria, Ugandan trial shows. (February 2015, AIDSmap)
- People With HIV Have High Risk of Invasive Pneumococcal Disease. (August 2014, Poz)
- Risk of invasive pneumococcal disease remains high for people living with HIV. (August 2014, AIDSmap)
